Focus Behavioral Health Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1101 Frederick Pike, Littlestown, PA 17340 Phone: 717-688-0362 |
News Archive
Hospital admissions for a dangerous heart infection related to intravenous drug use increased by 436 percent from 2012-2017 at a medical center in a region hit hard by the nation's opioid crisis, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase II protocol for the clinical study of Archexin as a treatment of ovarian cancer to the U.S. Food and Drug Administration (FDA).
The gene known to be associated with breast cancer susceptibility, BRCA 1, plays a critical role in the normal metabolic function of skeletal muscle, according to a new study led by University of Maryland School of Public Health researchers.
BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration (FDA) has approved a significant expansion of its ongoing ProMRI® trial.
› Verified 3 days ago